Keybanc analyst Todd Thomas upgrades VICI Props (NYSE:VICI) from Sector Weight to Overweight.
Lexaria Incorporates New Subsidiary For CPG Products And Updates Human Nicotine Study
Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has incorporated a new wholly-owned subsidiary under